Literature DB >> 1009360

Prazosin treatment complicated by acute febrile polyarthritis.

S A Cairns, S C Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1009360      PMCID: PMC1690399          DOI: 10.1136/bmj.2.6049.1424

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Antinuclear antibodies following hydralazine toxicity.

Authors:  J J Condemi; D Moore-Jones; J H Vaughan; H M Perry
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

Review 2.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

  2 in total
  6 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  Unanswered questions about prazosin hydrochloride.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

3.  Positive antinuclear factor tests with prazosin.

Authors:  A J Marshall; M E McGraw; D W Barritt
Journal:  Br Med J       Date:  1979-01-20

4.  Prazosin hydrochloride.

Authors:  J B Armstrong
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

Review 5.  Adverse effects of alpha 1-adrenergic blocking drugs.

Authors:  S G Carruthers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

Review 6.  Vasodilator therapy in chronic congestive heart failure.

Authors:  A B Schwartz; K Chatterjee
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.